IP Library Granted Patent US 7,642,248
Granted Patent B2
US 7,642,248 · App. 11/694,140 · Granted Jan 5, 2010

Devices and processes for distribution of genetic material to mammalian limb

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,642,248
App. No.
11/694,140
Granted
Jan 5, 2010
Kind
B2
Abstract

A process is described for the delivery of a therapeutic polynucleotide to limb muscle tissue suffering from or potentially suffering from Muscular Dystrophy. The polynucleotide is inserted into a mammalian limb vessel such as an artery. Delivery efficiency and distribution is enhanced by combining injection of a solution containing the polynucleotide with the use of an externally applied cuff.

Claims (13)

1. An in vivo process for delivering a polynucleotide to a limb muscle cell in a mammal affected by Muscular Dystrophy comprising:

a) inserting an injector into a blood vessel in the limb of the mammal;

b) applying a device external to mammalian skin for compressing vessels in an area underneath the device thereby occluding vessel fluid flow into and out of the limb; and,

c) injecting a solution containing the polynucleotide via the injector into the lumen of said blood vessel distal to the occlusion wherein the solution is retained within the limb, thereby increasing the volume of fluid in the limb and delivering the polynucleotide to the limb muscle cell in the limb.

2. The process of claim 1 wherein the polynucleotide is selected from the group consisting of viral vector and non-viral vector.

3. The process of claim 1 wherein the externally applied device consists of a tourniquet placed over the skin.

4. The process of claim 1 wherein the externally applied device consists of a cuff placed over the skin.

5. The process of claim 4 wherein the externally applied device consists of a sphygmomanometer cuff placed over the skin.

6. The process of claim 1 wherein the polynucleotide is expressed in the limb muscle cell.

7. The process of claim 6 wherein the polynucleotide encodes a peptide or protein.

8. The process of claim 7 wherein the peptide or protein is secreted from the muscle cell.

9. The process of claim 7 wherein the peptide or protein provides a therapeutic benefit to the mammal.

10. The process of claim 1 wherein the polynucleotide inhibits expression of an endogenous gene.

Assignments (3)
CHANGE OF NAME Recorded Feb 26, 2014
From: ROCHE MADISON INC.
To: ARROWHEAD MADISON INC.
Reel/Frame 032302/0843 →
CHANGE OF NAME Recorded Aug 10, 2009
From: MIRUS BIO CORPORATION
To: ROCHE MADISON INC.
Reel/Frame 023081/0128 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2008
From: WOLFF, JON A; BUDKER, TATYANA
To: MIRUS BIO CORPORATION
Reel/Frame 021441/0111 →